Table 2. Antibiotic resistance patterns of key pathogens.
Each bacterial isolate was tested against multiple antibiotics. Therefore, resistance counts across different antibiotics are not mutually exclusive, and a single isolate may be resistant to more than one antibiotic. As a result, the total number of resistant cases for a pathogen may exceed the number of isolates
MRSA: methicillin-resistant Staphylococcus aureus
| Pathogen (n) | Antibiotic | Resistant (n) | Resistant (%) |
| E. coli (n = 216) | Ciprofloxacin | 169 | 78.24 |
| Ceftriaxone | 153 | 70.83 | |
| Amikacin | 32 | 14.81 | |
| Imipenem | 14 | 6.48 | |
| S. aureus (n = 104) | Oxacillin (MRSA marker) | 67 | 64.42 |
| Clindamycin | 49 | 47.12 | |
| Vancomycin | 3 | 2.88 | |
| K. pneumoniae (n = 81) | Cefotaxime | 53 | 65.43 |
| Amikacin | 16 | 19.75 | |
| Imipenem | 8 | 9.88 | |
| P. aeruginosa (n = 63) | Piperacillin-tazobactam | 19 | 30.16 |
| Ceftazidime | 25 | 39.68 | |
| Meropenem | 10 | 15.87 |